News

Pharmabiz4h
Clearmind Medicine gets IRB nod from TASMC for phase 1/2a clinical trial to evaluate CMND-100 for treatment of alcohol use disorder
Clearmind Medicine gets IRB nod from TASMC for phase 1/2a clinical trial to evaluate CMND-100 for treatment of alcohol use disorder: Vancouver, Canada Saturday, July 5, 2025, 18:0 ...
Pharmabiz7h
Theratechnologies signs binding arrangement agreement with CB Biotechnology to buy all issued and outstanding common shares of the company
Theratechnologies signs binding arrangement agreement with CB Biotechnology to buy all issued and outstanding common shares of the company: Montreal Saturday, July 5, 2025, 15:00 ...
Pharmabiz5h
Dyadic International announces strategic rebrand to Dyadic Applied BioSolutions
Dyadic International announces strategic rebrand to Dyadic Applied BioSolutions: Jupiter, Florida Saturday, July 5, 2025, 17:00 Hrs [IST] Dyadic International, Inc, a global biote ...
Pharmabiz6h
Thermo Fisher Scientific’s NGS assay, Oncomine Dx Express Test receives US FDA approval as a companion diagnostic for Dizal’s Zegfrovy
Carlsbad, California Saturday, July 5, 2025, 16:00 Hrs [IST] ...
Pharmabiz8h
Ensem Therapeutics doses first patient in phase 1/2 clinical study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader
Ensem Therapeutics doses first patient in phase 1/2 clinical study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader: Waltham, Massachusetts Saturda ...
Pharmabiz10h
Onward Medical submits two major regulatory applications for its ARC-EX system; seeking clearance to expand its indication for home use
Onward Medical submits two major regulatory applications for its ARC-EX system; seeking clearance to expand its indication for home use: Eindhoven, the Netherlands Saturday, July ...
Pharmabiz9h
Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome
Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome: Waltham, Massachusetts Saturday, July 5, 202 ...
Pharmabiz11h
InnoCare Pharma gets China NMPA approval to conduct clinical trial for a novel ADC ICP-B794 in China
InnoCare Pharma gets China NMPA approval to conduct clinical trial for a novel ADC ICP-B794 in China: Beijing Saturday, July 5, 2025, 11:00 Hrs [IST] InnoCare Pharma, a commercial ...
Pharmabiz14h
DCC recommends DCGI to share SOPs and formats with States as per IDP
DCC recommends DCGI to share SOPs and formats with States as per IDP: Gireesh Babu, New Delhi Saturday, July 5, 2025, 08:00 Hrs [IST] The Drugs Consultative Committee (DCC) has re ...
Pharmabiz13h
AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer
AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer: Cambridge, UK Saturday, July 5, 2025, 09:00 Hrs [IST] AstraZen ...
Pharmabiz12h
HanchorBio inks licensing pact with Shanghai Henlius Biotech to develop & commercialise HCB101 across Greater China
HanchorBio inks licensing pact with Shanghai Henlius Biotech to develop & commercialise HCB101 across Greater China: Taipei, Shanghai Saturday, July 5, 2025, 10:00 Hrs [IST] Hanch ...
Pharmabiz10h
Kairali Ayurvedic Group opens first Ayurveda wellness centre in Jaipur
Kairali Ayurvedic Group opens first Ayurveda wellness centre in Jaipur: Our Bureau, Mumbai Saturday, July 5, 2025, 11:30 Hrs [IST] Kairali Ayurvedic Group, one of India’s most t ...